SEC Seeks Vaccine Manufacturer Input On Pediatric Stockpile Accounting
This article was originally published in The Pink Sheet Daily
Executive Summary
Securities & Exchange Commission regulations on revenue recognition are preventing childhood vaccine manufacturers from selling product to a government stockpile. Rep. Waxman declares support for a special exemption for vaccine makers.